Institute for Cancer Research
Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded.
The Institute has internationally strong research groups within biochemistry, cell and tumor biology, genetics, radiation biology, immunology and cancer prevention. For more than 30 years there has been a close interaction between researchers at the Institute and cancer surgeons, oncologists and pathologists. This emphasis on translational science has resulted in numerous clinical protocols based on in-house research, and the Institute is a key partner in the Comprehensive Cancer Center, organizationally under the Division of Surgery and Cancer Treatment at Oslo University Hospital.
Scientific production - Institute for Cancer Research
Speakers: professor Ole Andreassen, professor Ingrid Melle, scientist Torill Ueland, researcher Ingrid Dieset, associate professor Unn Haukvik and associate professor Lars T. Westlye, all from Norwegian Centre for Mental Disorders Research (NORMENT), University of Oslo (UiO) and OUH.
Time: Monday, October 6th, 2014, at 14:30-16:00.
Place: Blue Auditorium, Rikshospitalet, Sognsvannsveien 20, Oslo.
The K.G. Jebsen Colorectal Cancer Research Centre was recently officially opened by the chair of the Jebsen Foundation’s board of directors, Hans Peter Jebsen. Prof. Ragnhild A. Lothe will lead the Centre together with the interdisciplinary PI team consisting of Prof. Michael Bretthauer (gastroenterologist), Prof. Arild Nesbakken (surgeon), Prof. Kjell Tveit (oncologist) and ass. Prof. Rolf I. Skotheim (bioinformatician).
This is the only Jebsen Centre in Oslo that has Oslo University Hospital as its main host institution. Prof. Sigbjørn Smeland, head of the hosting Division of Cancer, Surgery and Transplantation, said in his talk that the Centre was an excellent example of how to organise and succeed in translational research within a Comprehensive Cancer Centre.
Thomson Reuters - the multinational media and information firm that operates in more than 100 countries, and has more than 60,000 employees around the world - has selected The "World's most influential scientific minds 2014".
They have listed some 3,200 researchers who published the greatest number of highly cited papers in one of 21 broad fields. These highly cited researchers were determined by analyzing at citation data over the last 11 years to identify those who published the highest-impact work (2002—2012 and 2012—2013). These individuals are influencing the future direction of their fields, and of the world.
Seven Norwegian scientists are on the list, and of these two researchers represent Oslo University Hospital. These are Rune Blomhoff from the Department of Clinical Service at the Divsion of Cancer, Surgery and Transplantation and Sverre Kjeldsen from the Department of Cardiology, at the Medical Clinic.
Three scientists recently received awards for their outstandig work at a ceremony taking place at Oslo University Hospital. This is the second year such prizes have been distributed in order to honour excellent scientific work.
The major prize - the "Excellent Researcher Award" - went to professor Ludvig M. Sollid. Edvard Leithe and Kyrre Eeg Emblem both received the "Early Career Award".
The prize money - 300.000 and 150.000 NOK respectively - is earmarked for research activities.
Magnus Løberg and Michael Bretthauer from the Department of Transplantation Medicine at Oslo University Hospital are first and last author respectively on an article recently published in New Eng J Med (journal impact factor 54.42), entitled "Long-Term Colorectal-Cancer Mortality after Adenoma Removal".
Taking advantage of nationwide data in the Cancer Registry of Norway on patients who have had colorectal adenomas removed, they have evaluated colorectal-cancer mortality in a large, population-based cohort with virtually complete follow-up for death from colorectal cancer.
The findings are commented in an editorial in NEJM.
Professor Øyvind S. Bruland, head of the Sarcoma group at the from the Department of Oncology at Oslo University Hospital, has together with Roy Hartwig Larsen won the University of Oslo Innovation Prize for 2014.
Bruland and his research has in this connection been thoroughly presented in UiO's web newspaper "Uniforum" and in UiO's research magazine "Apollon" (download in pdf format).
The decade of psychiatry - new knowledge about disease mechanisms and outcome
Sep 30, 2014
“Linking genotype to phenotype in cancer: proteostasis and metabolic reprogramming"
Sep 12, 2014
Inst. for Cancer Research
HLA-DQ Molecules as Affinity Matrix for Identification of Gluten T Cell Epitopes
J Immunol (in press)
Using normalization to resolve RNA-seq biases caused by amplification from minimal input
Physiol Genomics (in press)
Journal Impact Factor > 5, first or last author from the Institute for Cancer Research
Development of nanoparticles for clinical use
Nanomedicine (Lond), 9 (9), 1295-9
Genome-wide DNA methylation profiles in progression to
Genome Biol, 15 (8), 435 (in press)